Ribociclib Induces Broad Chemotherapy Resistance and EGFR Dependency in ESR1 Wildtype and Mutant Breast Cancer
Isabel Mayayo‐Peralta(The Netherlands Cancer Institute), Stefan Preković(The Netherlands Cancer Institute)
Cited by 8
Related Papers
Glucocorticoid receptor triggers a reversible drug-tolerant dormancy state with acquired therapeutic vulnerabilities in lung cancer
|Nature Communications|2021|79
Luminal breast cancer identity is determined by loss of glucocorticoid receptor activity
|EMBO Molecular Medicine|2023|26
PAXIP1 and STAG2 converge to maintain 3D genome architecture and facilitate promoter/enhancer contacts to enable stress hormone-dependent transcription
|Nucleic Acids Research|2023|21
Glucocorticoids regulate cancer cell dormancy
|bioRxiv (Cold Spring Harbor Laboratory)|2019|4
PAXIP1 and STAG2 converge to maintain 3D genome architecture and facilitate promoter/enhancer contacts to enable stress hormone-dependent transcription
|bioRxiv (Cold Spring Harbor Laboratory)|2022|2